US Stock MarketDetailed Quotes
NRXS Neuraxis
- 2.990
- -0.010-0.33%
Close Jun 7 16:00 ET
19.88MMarket Cap-1352P/E (TTM)
3.450High2.880Low16.97KVolume3.450Open3.000Pre Close52.06KTurnover0.54%Turnover RatioLossP/E (Static)6.65MShares6.93052wk High-6.24P/B9.45MFloat Cap1.80052wk Low--Dividend TTM3.16MShs Float6.930Historical High--Div YieldTTM19.00%Amplitude1.800Historical Low3.067Avg Price1Lot Size
About Neuraxis Company
NeurAxis, Inc. develops neuromodulation therapies to address chronic and debilitating conditions in children. Its product IB-Stim is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.
Company Profile
SymbolNRXS
Company NameNeuraxis
Listing DateAug 9, 2023
Issue Price6.00
Founded2011
CEOMr. Brian Carrico
MarketAMEX
Employees19
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11611 North Meridian Street,Suite 330
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-812-689-0791
Websitehttp://www.i-h-s.com
Company Executives
- Name
- Position
- Salary
- Brian Carrico
- President, Chief Executive Officer and Director
- 839.40K
- Adrian Miranda
- Chief Medical Officer, Senior Vice President, Science and Technology and Director
- 323.05K
- Dr. Thomas Carrico
- Chief Regulatory Officer, Compliance Officer and Privacy Officer and Director
- 411.10K
- Timothy Henrichs
- Chief Financial Officer
- 43.70K
- Christopher Robin Brown
- Independent Director
- --
- Bradley Mitch Watkins
- Independent Director
- 43.70K
- Kristin A. Ferge
- Independent Director
- --
- Beth Keyser
- Independent Director
- 43.70K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg